Cannabis industry expected to hit $41 Bi...

www.igethi.com  A unique beverage experience is now available! Good vibes at the Champs tradeshow, debuting the new **Drink 2 Joints** collab with Good Vibe Tribe, Sublime & The I heart radio crew for cannabis talk 101. Stay tuned...more Good vibes coming your way just in time fo ... Show More

Join us as we dive deep into Freeway Rick’s life journey, exploring his highs, lows, & relationship with cannabis today! From street hustler to motivational speaker & mentor, his story is a beacon of hope that reminds us all that transformation is within reach, no matter where we ... Show More

MR. #STFU, aka Little Brother of the Pot Brothers at Law Marc Wasserman, comes to talk about the movie Herbie. This Vietnam vet story is amazing. Produced by Ford Austin, this movie is creating a serious buzz at the movie festivals and winning awards. BEST ACTOR! Plus, Sheldon Co ... Show More

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades. Learn more about your ad-choices at https://www ... Show More

The Interview. Jason Wild, founder of JW Asset Management, sits down with Tony Greer, founder of TG Macro, to discuss his career journey from pharmacist to investor with a firm that oversees $1 billion through a mix of investments in pharmaceuticals and cannabis producers. Wild’s ... Show More

Tezlyn chats with Dr. Lance McCarthy about how Black Americans can benefit from the cannabis industry beyond owning a dispensary and how the industry is changing the criminal justice system.   Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio. ... Show More

<p>In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019.&nbsp;</p><br><p>Read ... Show More

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ... Show More

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billi ... Show More

This week, we go one toke over the line and look at the emerging world of cannabis marketing.We start with the question - just how does a plant become illegal?We’ll explore the history of cannabis.We’ll talk about which celebrities have their own brands (Hello Willie Nelson!)Whic ... Show More

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ... Show More

In today's episode, we discuss issues in the pharmaceutical industry, how pharmacists are dealing with the pandemic, and how the role of the pharmacist is evolving. "If you don't want to be in the business of serving, then get out of pharmacy." - Todd Eury Take the Corepreneur Se ... Show More